Clinical Trials on Seasonal Allergic Rhinitis in United Kingdom

Total 1097 results

University of East Anglia
Norfolk and Norwich University Hospitals NHS Foundation Trust; Quadram Institute... and other collaborators

Completed

Seasonal Allergic Rhinitis Study (SAR)

Asthma | Grass Allergy | Seasonal Affective Rhinitis

United Kingdom
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals; PPD; Rho Federal Systems Division, Inc.; ALK-Abelló A/S and other collaborators

Active, not recruiting

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction (GRADUATE)

Grass Pollen Allergy | Allergic Rhinoconjunctivitis

United Kingdom
Revolo Biotherapeutics

Completed

Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United Kingdom
Pfizer

Completed

Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers

Seasonal Allergic Rhinitis

United Kingdom
Novartis Pharmaceuticals

Completed

A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance

Seasonal Allergic Rhinitis

United Kingdom
Novartis

Completed

Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen

Seasonal Allergic Rhinitis

United Kingdom
University of Florida
Wakunaga Pharmaceutical Co., Ltd.

Completed

Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies (JEN)

Healthy

United States
West Penn Allegheny Health System
Pennsylvania Allergy and Asthma Research Foundation

Completed

Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections

Allergy | Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis

United States
GlaxoSmithKline

Completed

A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.

Sinusitis | Seasonal Allergic Rhinitis

United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Seasonal Allergic Rhinitis | SAR

United States
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) (GSP 301-305)

Seasonal Allergic Rhinitis (SAR)

United States
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-304)

Seasonal Allergic Rhinitis (SAR)

United States
United Allergy Services

Unknown

Microassay and Allergy Skin Prick Test Correlation Study

Allergy Pollen

United States
GlaxoSmithKline

Completed

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Rhinitis, Allergic, Perennial and Seasonal

United States
Teva Pharmaceuticals USA

Terminated

Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
University of Chicago

Unknown

Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis

Allergic Rhinitis

United States
University of Chicago

Completed

Vitamin D Plus Fluticasone Propionate

Seasonal Allergic Rhinitis

United States
Capnia, Inc.

Completed

The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Pfizer

Completed

A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.

Allergic Rhinitis

United States
Sanofi

Completed

Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Johns Hopkins University

Completed

DNA Vaccine for Ragweed Allergic Adults

Seasonal Allergic Rhinitis

United States
Imperial College London
Novartis Pharmaceuticals

Completed

Repeat Nasal Allergen Challenge

Hayfever

United Kingdom
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older

Seasonal Allergic Rhinitis

United States
Padagis LLC

Completed

A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Capnia, Inc.

Completed

The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Alcon Research

Completed

Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid

Seasonal Allergic Rhinitis

United States
Apotex Inc.

Completed

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Merck Sharp & Dohme LLC

Completed

A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Magna Pharmaceuticals, Inc.

Completed

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects (STA-2)

Seasonal Allergic Rhinitis

United States
University of Chicago

Completed

Allergic Rhinitis Changes the Sinus Microbiome

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

Seasonal Allergic Rhinitis

United States
Northwestern University

Completed

Reduction of IgE Antibody in Human Allergic Subjects

Seasonal Allergic Rhinitis

United States
Teva Pharmaceuticals USA

Unknown

Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

Seasonal Allergic Rhinitis

United States
University of Chicago
Schering-Plough

Terminated

Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
University of Chicago
Schering-Plough

Completed

Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?

Seasonal Allergic Rhinitis

United States
University of Chicago
GlaxoSmithKline

Completed

Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms

Seasonal Allergic Rhinitis

United States
University of Chicago
GlaxoSmithKline

Completed

Intranasal Steroids and the Nasal Ocular Response

Seasonal Allergic Rhinitis

United States
Alcon Research

Completed

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial

Seasonal Allergic Rhinitis

United States
Alcon Research

Completed

Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients

Seasonal Allergic Rhinitis

United States
University of Mississippi Medical Center
Kyowa Hakko Kogyo Co., Ltd.

Completed

Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Allergy Therapeutics
SynteractHCR; Metronomia Clinical Research GMBH

Completed

A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL (G104)

Seasonal Allergic Rhinitis

United States
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
Allergy Therapeutics

Completed

Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™

Seasonal Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

Allergic Rhinitis | Seasonal Allergic Rhinitis

United States
Sanofi

Completed

Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit

Seasonal Allergic Rhinitis

United States

3

Subscribe